Despite the presence of a pathogenic variant in the X-linked Glucose-6-Phosphate Dehydrogenase gene, no haemolytic crisis occurred before the diagnosis of rhabdomyosarcoma, and no excessive transfusions were necessary during chemotherapy. This evidence concerns the gene G6PD and rhabdomyosarcoma.